BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Tech Shares'. (Return)

MarketWatch MarketPulseDec 10, 2018
UPDATE: Axsome Therapeutics shares soar 24% premarket on positive trial of Alzheimer's therapy
Shares of Axsome Therapeutics Inc. surged about 24% premarket Monday, after the biotech, which specializes in therapies for central nervous system disorders, reported positive results in an interim analysis of a trial of a treatment for the agitation associated with Alzheimer's disease. An independent data monitoring committee (IDMC) recommended continuing the Phase 1/2 trial of AXS-05 and did not indicate any safety concerns. The company intends to follow the committee's recommendation. "We anticipate that implementation of the IDMC's recommendations may provide greater flexibility to our operating plans and timelines which we will evaluate in the coming weeks," Chief Executive Herriot Tabuteau said in a statement. Roughly 70% of Alzheimer's patients suffer from agitation, which can be highly upsetting for patients and caregivers. There is currently no approved treatment for the condition. Axsome shares have fallen 47% in 2018, while the S&P 500 has fallen 1.5%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



RELATED ARTICLES
UPDATE: Axovant shares slide 30% premarket after trial of treatment for sleep disorder fails to meet main goal (MarketWatch MarketPulse)
TRENDING TAGS
ChinaHuawei trade US-China Qualcomm iPhones
Brexitvote UK Court rules deal
GhosnNissan Carlos charged indicted financial
futuresweek sell-off Dow Stock looks
Trumpchief staff were private transaction
TradeUS-China Huawei arrest China Stocks
stockglobal growth futures buy market
NissanGhosn indicted charged Carlos Japan
HuaweiChina arrest Canada CFO bail
FilerINC 8-K 497K FUNDS T

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact

©1999-2018 CEOExpress Company LLC